Share This


Herein we report two cases of toxic anterior segment syndrome (TASS) following uneventful cataract surgery. Both patients presented 24 hours after their uneventful operations with painless blurred vision in the operated eye. The inflammatory reaction was controlled successfully with an intensive regime of preservative-free dexamethasone drops. TASS can have devastating consequences for patients if not identified or mistaken for endophthalmitis, which can present similarly.

We aim to review the presentation, aetiology, prevention and management of TASS and also discuss how to differentiate it from infective endophthalmitis. An outbreak of TASS is an environmental and surgical issue that requires detailed analysis of the cataract operation, including preparations of drugs administered, as well as reviewing the operating theatres and sterilisation protocols.


Cataract surgery is the most common operation performed in the UK with approximately 400,000 cataract operations undertaken in England and 20,000 in Wales in the 2016-2017 NHS year [1]. This number is expected to grow by 25% in the next 10 years [2]. A highly successful operation but not without its potential risks, one of which is severe inflammation. Toxic anterior segment syndrome (TASS) is an acute, sterile postoperative anterior segment inflammation following any anterior segment surgery [3]. It most commonly occurs after cataract surgery but any anterior segment surgery can trigger this inflammatory response. Here we describe two such cases following uneventful cataract surgery

Case 1

A 72-year-old lady presented with blurred vision one day after a routine cataract operation to her left eye. Her past medical history included type 2 diabetes and hypertension, which were both well controlled. She had very mild dry age-related macular degeneration (AMD) in both eyes and had previously had uncomplicated cataract surgery to her right eye. Twenty-four hours following her left cataract operation, the patient noticed significant reduction in her visual acuity. She denied any pain. On examination, there was significant diffuse limbus to limbus corneal oedema. Hypopyon, fibrin deposits, flare and inflammatory cells were seen in the anterior chamber. There was no view of the posterior segment on biomicroscopy but B-scan did not show any evidence of posterior segment inflammation.

Case 2

An 82-year-old lady who was on the same theatre list as the above patient, also presented 24 hours after an uneventful cataract operation in her right eye. The clinical presentation was exactly the same: reduced visual acuity, corneal oedema, hypopyon, fibrin deposits, flare and inflammatory cells in the anterior chamber of the eye. Both patients were started on the following regime of drops:

  • preservative free Gt. chloramphenicol four times a day
  • preservative free Gt. cyclopentolate 1% twice a day
  • an intensive regime of preservative free dexamethasone 1mg/ml drops every 30 mins for the first two days which was then reduced to every hour thereafter

As the inflammation settled, the topical steroid therapy was tapered down over the following weeks. Both patients have done well and four weeks after their presentation, there was a significant improvement in the anterior chamber reaction. They are now being monitored at regular intervals to monitor their corneal oedema, which is still present in both cases.


TASS is a sterile postoperative inflammation that is thought to be triggered by damage to intraocular tissue by a substance introduced to the anterior segment during surgery. There have been cases of delayed presentation of TASS following implantation of a specific intraocular lens (ISert model 251) between 42 days and 137 days after implantation but the majority of TASS cases occur 12-48 hours after the operation, with the most common complaint being blurred vision [4]. On clinical examination, patients present with limbus to limbus corneal oedema (Figure 1) as a result of toxicity to the endothelial cells. Significant anterior inflammation is seen as an increase in inflammatory cells, which may settle to form a hypopyon. Flare and fibrin formation are other common findings in TASS (Figure 1).


Figure 1: Limbus to limbus corneal oedema, anterior segment inflammation including hypopyon seen in a patient with TASS. Image reproduced with permission from Ahmed R Alghoul, University of Calgary Faculty of Medicine, Canada, published by Medscape Drugs & Diseases (, Toxic Anterior Segment Syndrome (TASS), 2017, available at:



Damage to the iris following the toxic substance and inflammatory response can lead to an irregular or permanently dilated pupil.

Involvement of the trabecular meshwork can also lead to secondary glaucoma, which may be difficult to control. Regular monitoring of intraocular pressure (IOP) is imperative, especially in the acute stages of this condition.

TASS can present very similarly to infective endophthalmitis. It is important to differentiate the two entities in order to manage them appropriately. Table 1 demonstrates the main differences. Inflammatory changes such as an increase in inflammatory cells, flare and the presence of a hypopyon within the anterior chamber are very similar in both conditions.



Table 1: A comparison between the clinical presentation of TASS and infective endophthalmitis.


Timing: 12-24 hours post-op
Pain: None to mild (unless increased IOP when it can be servere)
Conjunctival reaction: Minimal
Coreneal oedema: Limbus-to-limbus
Timing: Around three to five days post-op
Pain: Painful
Conjunctival reaction: More
Coreneal oedema: Localised




The timing of the onset of symptoms postoperatively is one of the more helpful ways in differentiating between TASS and endophthalmitis. TASS usually occurs within the first 12-48 hours whereas, endophthalmitis tends to present much later, around seven to 10 days post-op [3]. The pattern of corneal oedema can also be useful. The diffuse limbus-to-limbus corneal oedema seen in TASS is not usually seen in endophthalmitis [5]. Up to 75% of patients who have an infectious endophthalmitis may also complain of pain, whereas patients with TASS rarely complain of pain unless their IOP is increased secondary to trabecular meshwork damage [5].

The management of these two conditions varies significantly. Someone who is suspected to have infective endophthalmitis has to be taken back to theatre in order to obtain a vitreous tap and administer antibiotics. TASS on the other hand does not respond to antibiotic treatment and requires an intensive regime of topical steroids. If there are any doubts, however, of an infective cause of post-op inflammation, samples should be taken for culture and intravitreal antibiotics should be administered as per the local guidelines.

Aetiology of TASS

There is a wide rage of potential toxic substances that can damage the corneal endothelium and trigger the inflammatory response in TASS after cataract surgery. Any ophthalmic solutions used during surgery, such as balanced salt solution (BSS), any additives, antibiotics or ophthalmic viscosurgical devices (OVDs) may cause significant postoperative inflammation [6]. Enzymes or detergents used for the sterilisation of surgical instruments can also cause TASS [7]. We review each of these in turn.

Intraocular irrigating solutions

Incorrect composition, osmolarity or pH of the BSS can provoke an inflammatory reaction. Contamination of BSS caused 122 cases of TASS in the United States in 2005. Investigation by the Intermountain Ocular Research Centre at the University of Utah, as well as investigators from the United States Centres for Disease Control (CDC) found that the vast majority of patients were exposed to one particular brand of BSS that was used during cataract surgery. Samples from multiple batches of BSS were tested for endotoxin levels and one particular manufacturer was found to have levels of endotoxin exceeding the allowable limit of 0.5 EU/mL in the BSS.

Additives to the solutions, such as mydriatics or antibiotics, can also cause TASS [8]. Lockington et al. found free radicals in commonly used intracameral drug preparations, such as phenylephrine, cefuroxime, lidocaine and bevacizumab, which can induce a dose dependent cellular damage [8].


The most common preservative in ophthalmic drops, benzalkonium chloride, although safe to use on the surface of the eye, is known to be toxic to the corneal endothelium [9]. When used as a preservative in OVDs it has been known to lead to corneal oedema [10]. Stablising agents such as bisulphites or metabisulphites can also be toxic to the cells within the anterior segment of the eye and can lead to TASS [11].

Intraocular anaesthetic

Preservative free lidocaine at concentrations of 2% or higher delivered intracamerally have been known to be toxic to the endothelium. This in turn has been shown to cause corneal thickening and opacification [8].

Intraocular antibiotics

The European Society of Cataract & Refractive Surgeons (ESCRS) multicentre study of the prophylaxis of endophthalmitis after cataract surgery showed a clear benefit of using intracameral cefuroxime to significantly reduce the risk for developing endophthalmitis after cataract surgery [12]. Koban et al. reported that a high dose (20 mg/0.5 ml) of gentamicin, prepared for subconjunctival injection, inadvertently injected into the eye, induced severe TASS and bullous keratopathy [13].

Ophthalmic viscosurgical devices

The use of OVD’s has been common practice in cataract surgery since the introduction of Healon (sodium hyaluronate 1%) in 1979. Kim JH showed in three successive cases, that injection of denatured OVD leads to intraocular inflammation [6].

Intraocular (IOL) lens contamination

There have been multiple reports of contaminated IOLs causing TASS. Contamination of IOLs with aluminium was thought to be the cause of 147 cases of TASS between 2015 and 2016 in Japan [5]. Suzuki et al. also report 251 cases of TASS following the use of a specific type of IOL (HOYA iSert®) [14].

Patient factors

A retrospective case-controlled study by Yazqan et al. suggested that systemic factors such as poorly controlled type 2 diabetes, hypertension and hyperlipidemia may increase the risk of TASS after uneventful cataract surgery [15].

Sterilisation of ophthalmic instruments

The American Society of Cataract and Refractive Surgery (ASCRS) funded and established the TASS Task Force to investigate and monitor any outbreaks of TASS in 2006. The Canadian Ophthalmology society also has a TASS task force, which serves to investigate any outbreaks of TASS and offer guidance on appropriate prevention and management of the condition. Some of this guidance is on appropriate cleaning and sterilisation of intraocular surgical instruments.

The ASCRS TASS task force found that the use of enzymatic detergents and ultrasound baths can cause TASS. Most autoclaves used to sterilise medical equipment at temperatures of 138°C, wheres enzymes used as detergents are only deactivated at temperatures of 140°C [16]. Rabbit models have also shown significant endothelial damage due to enzymatic detergents [7].

Management of TASS

Firstly, it is essential that an infectious case of the post-op inflammation has been ruled out. Once this has been established, the mainstay of treatment is suppression of the secondary inflammation by topical steroids. Gutt. prednisolone acetate 1% or dexamethasone 0.1% is the initial choice of treatment [17]. The frequency of instillation is determined by the severity of the inflammation. Mild cases require drops eight times a day and, as in our severe cases, this can be increased three-fold with drops administered every 30 minutes.

In some cases, intracameral injection of recombinant tissue type plasminogen activator (25μg/0.1ml) may be required if the fibrin reaction is refractory to steroid treatment [4].

The patient requires close follow-up, especially in the first few days to monitor the response to treatment and also monitor the IOP. Inflammation within the anterior chamber can lead to damage to the trabecular meshwork as well as the ciliary body. As the inflammation settles, the ciliary body regains its function and, as more aqueous is produced, the IOP can rise, especially if there has been an inflammatory insult to the trabecular meshwork. Furthermore, if the inflammation is not responding to steroid therapy, one has to re-consider the possibility of an infective cause and a vitreous tap or a repeat culture may be required.

As mentioned above, delayed presentations of TASS may occur as a result of faulty or contaminated IOLs, as demonstrated by Oshika et al. and Suzuki et al. In these cases patients may require further surgical intervention, such as anterior chamber irrigation, anterior vitrectomy, vitrectomy and IOL removal [5,14].

Surgical intervention may also be required in severe cases of TASS where there is persistent corneal oedema secondary to permanent endothelial damage [18]. The time interval between the onset of TASS and the endothelial keratoplasty is crucial for successful surgical outcomes as demonstrated by Kaur et al. [18]. Endothelial keratoplasty, three months after the onset of TASS resulted in 100% success rate, whereas grafts performed within the first three months after the onset of TASS resulted in a high rate of graft failure. TASS can also lead to secondary glaucoma, which can be difficult to manage. IOP lowering drops are trialled first and if the IOP is not controlled with topical therapy, glaucoma surgery may be required [19]. Cystoid macular oedema secondary to TASS can be treated with intravitreal anti-VEGF or steroid injection [20].

Investigating the aetiology

For any case of TASS, it is advised that the surgical facility stops operations and investigates the potential causes. Any recent changes in surgical staff, IOLs, OVDs, surgical drapes, solutions, gloves, new machines, etc. should be considered as a possible source of contamination. Sharing such information with other surgeons in the area can help to contain a potential outbreak of TASS.


TASS prevention protocols, raising awareness of TASS, regularly training staff and following strict guidelines on appropriate cleaning and sterilisation of ophthalmic equipment all play a role in preventing TASS. The ASCRS, American Academy of Ophthalmology (AAO) and American Society of Ophthalmic Registered Nurses (ASORN) have published guidelines on how to clean and sterilise intraocular surgical instruments to prevent TASS, which are easily available for all members of the surgical team to access.



1. National Ophthalmology Database Audit Key Findings Summary 2018.
2. The Way Forward: Options to help meet demand for the current and future care of patients with eye disease. The Royal College of Ophthalmologists.
3. Bodnar Z, Clouser S, Mamalis N. Toxic anterior segment syndrome: update on the most common causes. J Cataract Refract Surg 2012;38(11):1902 10.
4. Miyake G, Ota I, Miyake K, et al. Late-onset toxic anterior segment syndrome. J Cataract Refract Surg 2015;41(3):666-9.
5. Oshika T, Eguchi S, Goto H, Ohashi Y. Outbreak of subacute-onset toxic anterior segment syndrome associated with single-piece acrylic intraocular lenses. Ophthalmology 2017;124:519-23.
6. Kim JH. Intraocular inflammation of denatured viscoelastic substance in cases of cataract extraction and lens implantation. J Cataract Refract Surg 1987;13:537-42.
7. Parikh C, Sippy BD, Martin DF, Edelhauser HF. Effects of enzymatic sterilization detergents on the corneal endothelium. Arch Ophthalmol 2002;120:165-72.
8. Lockington D, Macdonald EC, Young D, et al. Presence of free radicals in intracameral agents commonly used during cataract surgery. Br J Ophthalmol 2010;94(12):1674-7.
9. Bielory BP, Shariff A, Hussain RM, et al. Toxic anterior segment syndrome: inadvertent administration of Intracameral Lidocaine 1% and phenylephrine 2.5% preserved with 10% Benzalkonium chloride during cataract surgery. Cornea 2017;36:621-4.
10. Liu H, Routley I, Teichmann K. Toxic endothelial cell destruction from intraocular benzalkonium chloride. J Cataract Refract Surg 2001;27:1746-50.
11. Slack JW, Edelhauser HF, Helenek MJ. A bisulfite-free intraocular epinephrine solution. Am J Ophthal 1990;110:77-82.
12. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006;32:407-10.
13. Koban Y, Genc S, Bilgin G, et al. Toxic anterior segment syndrome following phacoemulsification secondary to overdose of Intracameral gentamicin. Case Rep Med 2014;2014:143564.
14. Suzuki T, Ohashi Y, Japanese ophthalmological society HIL-REIC, et al. Outbreak of late-onset toxic anterior segment syndrome after implantation of one-piece intraocular lenses. Am J Ophthalmol 2015;159(5):934-9.
15. Yazgan S, Celik U, Ayar O, et al. The role of patient’s systemic characteristics and plateletcrit in developing toxic anterior segment syndrome after uneventful phaco surgery: a case-control study. Int Ophthalmol 2018;38(1):43-52.
16. Parikh C, Sippy BD, Martin DF, Edelhauser HF. Effects of enzymatic sterilization detergents on the corneal endothelium. Arch Ophthalmol 2002;120(2):165-72.
17. Moyle W, Yee RD, Burns JK, Biggins T. Two consecutive clusters of toxic anterior segment syndrome. Optom Vis Sci 2013;90(1):e11-e23.
18. Kaur M, Titiyal JS, Falera R, et al. Outcomes of Descemet stripping automated endothelial keratoplasty in toxic anterior segment syndrome after phacoemulsification. Cornea 2017;36(1):17‑20.
19. Werner L, Sher JH, Taylor JR, et al. Toxic anterior segment syndrome and possible association with ointment in the anterior chamber following cataract surgery. J Cataract Refract Surg 2006;32(2):227-35.
20. Ugurbas SC, Akova YA. Toxic anterior segment syndrome presenting as isolated cystoid macular edema after removal of entrapped ophthalmic ointment. Cutan Ocul Toxicol 2010;29(3):221-3.


  • TASS is a rare but important complication that can occur following cataract surgery.
  • Patients usually present within one or two days following cataract operation with blurred vision being the most common symptom.
  • Anterior chamber reaction with limbus to limbus corneal oedema are classical signs of this condition.
  • It is of great importance that this entity is differentiated from infective endophthalmitis and if there is any doubt, samples should be taken for culture and treatment for infective endophthalmitis started.
  • Regular training and strict guidelines on the sterilisation of equipment used can avoid this complication, which can lead to secondary glaucoma or permanent corneal oedema that may require transplantation.
  • If there is an outbreak of TASS, a thorough investigation of possible aetiologies and sharing such information with colleagues is critical in raising awareness and preventing new cases of TASS.





Share This
Siddarth Nardeosingh

West of Scotland Deanery, UK.

View Full Profile